Trial Enrollment Information
Expanded Access Study of Melphalan CS-PHP with Delcath System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
Our Expanded Access Program (EAP) in the United States is now open for enrollment
Ongoing Clinical Trials
At present, we have one ongoing phase 2 clinical trial. This trial is closed to new enrollment.
Phase 2 Trial
This study was a phase 2 trial in which patients with unresectable cancers confined to the liver received treatments with melphalan via the Delcath System.
Completed Clinical Trials
Recently completed clinical trials are those that have passed the active data collection and treatment stage, but have not yet been published.
Treatment of Metastatic Melanoma in the Liver (Ocular and Cutaneous) With Melphalan
Clinical Bibliography
Browse our library of publications and abstracts
Disclaimer
Disclaimer: Delcath does not make any claim whatsoever, real or implied, about the efficacy or safety of any therapy, drug, system, or technique under active research.
